Program

 Program at a glance

To read the PDF file you will need Adobe Reader installed on your computer.

Ⓔ = English Session

Presidential Lecture

Friday, October 20　13:45-14:15 No. 1 (Hall Building Hall C, 4F)

Molecular-targeted therapy: From vitamins to innovative drugs

Chair:	Keisuke Toyama (Tokyo Medical University, Japan)
Speaker:	Masahiro Kizaki (Dept. Hematol., Saitama Med. Ctr., Saitama Med. Univ., Saitama, Japan)

Ⓔ Special Lecture

Friday, October 20　14:15-14:55 No. 1 (Hall Building Hall C, 4F)

Evolution of the term preleukemia

Chair:	Masahiro Kizaki (Dept. Hematol., Saitama Med. Ctr., Saitama Med. Univ., Saitama, Japan)
Speaker:	H. Phillip Koeffler (Cancer Science Institute of Singapore, National University of Singapore, Singapore/National University Cancer Institute of Singapore, National University Hospital, Singapore/Cedars-Sinai Medical Center, Los Angeles, USA)

Ⓔ ASH Special Lecture

Saturday, October 21　11:20-12:00 No. 1 (Hall Building Hall C, 4F)

New insights into therapeutic targets in multiple myeloma

Chair:	Kinuko Mitani (Department of Hematology and Oncology, Dokkyo Medical University, Japan)
Speaker:	Kenneth C. Anderson (Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA)

Ⓔ EHA Special Lecture

Friday, October 20　11:20-12:00 No. 1 (Hall Building Hall C, 4F)

New therapeutic developments in multiple myeloma

Chair:	Yuzuru Kanakura (Dept. of Hematology and Oncology, Osaka Univ. Graduate Sch. of Medicine, Japan)
Speaker:	Pieter Sonneveld (Professor of Hematology, Erasmus MC Rotterdam, The Netherlands)

JSH Award Lecture

Sunday, October 22　11:25-12:10 No. 1 (Hall Building Hall C, 4F)

Chairs:

Koichi Akashi (Dept. of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University, Japan)

The laboratory markers of immune pathophysiology in hematopoietic failure: Their usefulness for patient care and immuno-hematology research

Speaker:

Shinji Nakao (Department of Hematology & Pulmonary Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan)

Ⓔ Plenary Session

Saturday, October 21　13:10-14:40 No. 1 (Hall Building Hall C, 4F)

Chairs:	Itaru Matsumura (Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan)
	Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine, Japan)

Molecular mechanisms of leukemia stem cell maintenance by MLL fusion proteins

Speaker:

Akihiko Yokoyama (Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan)

iPSC model of Shwachman syndrome reveals the apoptotic predisposition of hemoangiogenic progenitors

Speaker:

Takayuki Hamabata (Pediatrics, Kyoto Univ., Kyoto, Japan)

CD98 turns into a specific target for antibody therapy under severe ER stress in multiple myeloma

Speaker:

Naoki Hosen (Cancer Stem Cell Biology, Osaka Univ., Osaka, Japan)

Establishment of the novel prognostic model of DLBCL based on microenvironment signature

Speaker:

Kohta Miyawaki (Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan)

Identification and visualization of FVIII-producing cells in vivo

Speaker:

Morisada Hayakawa (Department of Biochemistry, Jichi Medical University, Tochigi, Japan)

Specific effect of azacitidine for TP53 (+) MDS

Speaker:

Yasuhito Nannya (Pathol. & Tumor Biol., Kyoto Univ., Kyoto, Japan)

Ⓔ Presidential Symposium

Friday, October 20　15:10-17:20 No. 1 (Hall Building Hall C, 4F)

Young Japanese hematologists in the world:
Molecular pathogenesis of leukemia and leukemic stem cell (LSC)

Chairs:	Scott A. Armstrong (Dana-Farber Cancer Institute, Boston, MA, USA)
	Stephen D. Nimer (Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, FL, USA)

Application of super-enhancer profiling to the understanding of molecular pathogenesis and the identification of novel therapeutic targets in T-cell leukemia

Speaker:

Takaomi Sanda (Cancer Science Institute of Singapore, National University of Singapore, Singapore)

Metabolism, control of cell fate decisions, and stem cell renewal

Speaker:

Keisuke Ito (Albert Einstein College of Medicine, NY, USA)

Hormonal regulation of hematopoietic stem cell

Speaker:

Daisuke Nakada (Baylor College of Medicine, Houston, TX, USA)

Hematopoietic stem cell (HSC)-independent hematopoiesis and HSC diversity in the mouse embryo

Speaker:

Momoko Yoshimoto (Center for Stem Cell Research, IMM, McGovern Medical School, UTHealth at Houston, TX, USA)

Transcription-based therapies for acute myeloid leukemia

Speaker:

Susumu Kobayashi (Beth Israel Deaconess Medical Center, Boston, MA, USA)

Ⓔ JSH-ASH Joint Symposium (Symposium 7)

Sunday, October 22　9:00-11:10 No. 1 (Hall Building Hall C, 4F)

New insights into AML biology

Chairs:	Kenneth C. Anderson (Dana-Farber Cancer Institute, Harvard Medical School, USA)
	Koichi Akashi (Dept. of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University, Japan)

TET dioxygenase activity in the development of acute myeloid leukemia

Speaker:

Shigeru Chiba (Hematol., Univ. Tsukuba, Tsukuba, Japan)

Targeting epigenetic mechanisms to reverse leukemia stem cell gene expression

Speaker:

Scott A. Armstrong (Dana-Farber Cancer Institute, Boston, MA, USA)

Functional role of DNMT3A mutation in acute myeloid leukemia

Speaker:

Junji Koya (Department of Hematology and Oncology, The University of Tokyo Hospital, Tokyo, Japan)

Leukemia stem cells play a central role in therapy failure and disease recurrence in human AML

Speaker:

John E. Dick (Princess Margaret Cancer Centre and University of Toronto, Canada)

Ⓔ JSH-EHA Joint Symposium (Symposium 5)

Saturday, October 21　14:50-17:00 No. 1 (Hall Building Hall C, 4F)

Novel treatment strategy for MM using novel drugs in combination with immune modulation

Chairs:	Pieter Sonneveld (Erasmus MC, The Netherlands)
	Shinsuke Iida (Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan)

Modulation of innate immunity as a mechanism of Lenalidomide maintenance for multiple myeloma

Speaker:

Yusuke Furukawa (Div. Stem Cell Reg., CMM, Jichi Med. Univ., Tochigi, Japan)

Clinical application of Daratumumab for myeloma

Speaker:

Henk M. Lokhorst (VU University Medical Center, Amsterdam, The Netherlands)

Clinical development of CAR-T therapy for multiple myeloma

Speaker:

Ken Ohmine (Div. of Hematology, Dept. of Med., Jichi Medical Univ., Tochigi, Japan/ Div. of Immuno.-Gene. and Cell Therapy (Takara Bio), Jichi Medical Univ., Tochigi, Japan)

Basic and clinical research on PD-1/PD-L1 in multiple myeloma

Speaker:

Hermann Einsele (Haematology and Oncology, University Hospital Wüerzburg, Germany)

Ⓔ Asian Joint Panel Discussion

Saturday, October 21　9:00-11:10 No. 7 (Hall Building Hall D5, 5F)

MDS/MPN: Progress of basic and clinical research in Asia

Chairs:	Hyeoung-Joon Kim (General Director/CEO, Chonnam National University, Hwasun Hospital, Korea)
	Norio Komatsu (Juntendo University School of Medicine, Hematology, Japan)

Advances in clinical and basic researches in MDS

Speaker:

Yasuhito Nannya (Dept. of Pathol. and Tumor Biol., Kyoto Univ., Kyoto, Japan)

Spectrum & flowcytometry study in primary MDS

Speaker:

Hara Prasad Pati (Dept. of Hematology, All India Institute of Medical Sciences, New Delhi, India)

Incidence and characteristics of polycythemia Vera, essential thrombocythemia and primary myelofibrosis in Thailand: A patient cohort in the tertiary care hospital

Speaker:

Noppadol Siritanaratkul (Division of Hematology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand)

B cell immune profiles in essential thrombocythemia

Speaker:

Ken-Hong Lim (Division of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan/Department of Medicine, MacKay Medical College, New Taipei City, Taiwan)

Asian CML: How different is it from the West?

Speaker:

Thuan Heng Charles Chuah (Department of Haematology, Singapore General Hospital, Singapore/Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore)

Patient-reported outcomes in patients with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy in china

Speaker:

Qian Jiang (Peking University People's Hospital, Peking University Institute of Hematology, China)

The future prospects for treatment free remission in CML

Speaker:

Dong-Wook Kim (Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea)

Symposium

Ⓔ Symposium 1

Friday, October 20　9:00-11:10 No. 1 (Hall Building Hall C, 4F)

Control of immune microenvironment in tumor

Chairs:	Yoshiki Akatsuka (Dept. of Hematology, Fujita Health University, Japan)
	Hiroshi Fujiwara (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan)

The preclinical study of iPSC-derived CTL therapy with a safeguard system

Speaker:

Miki Ando (Transfusion Medicine and Stem Cell Regulation, Juntendo University, Japan/Stem Cell Therapy, The Institute of Medical Science, Tokyo University, Japan)

Clinical development of de-fucosylated anti-CCR4 and CD 4 antibodies for the treatment of cancer

Speaker:

Kouji Matsushima (Mol. Preventive Med., The University of Tokyo, Tokyo, Japan)

Personalized modulation of tumor immune-microenvironments for development of effective combination immunotherapy

Speaker:

Yutaka Kawakami (Institute for Advanced Medical Research, Keio University School of Medicine, Japan)

The tumor microenvironment in B cell lymphomas

Speaker:

Christian G. Steidl (Lymphoid Cancer Research, BC Cancer Agency, Vancouver, Canada/Pathology, University of British Columbia, Vancouver, Canada)

Ⓔ Symposium 2

Friday, October 20　9:00-11:10 No. 5 (Hall Building Hall B5(2), 5F)

Anemia and ineffective erythropoiesis

Chairs:	Hideo Harigae (Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan)
	Etsuro Ito (Department of Pediatrics, Hirosaki University Graduate School of Medicine and School of Medicine, Japan)

Regulation of fetal hemoglobin expression by the LRF transcription factor

Speaker:

Takahiro Maeda (Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan)

Ineffective erythropoiesis in myelodysplastic syndrome

Speaker:

Atsushi Iwama (Dept. Cell. Mol. Med., Graduate School of Medicine, Chiba University, Japan)

Hemoglobinopathy in Southeast Asia

Speaker:

Suthat Fucharoen (Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Salaya Campus, Nakornpathom, Thailand)

The role of iron in ineffective erythropoiesis

Speaker:

Clara Camaschella (Vita Salute University and San Raffaele Scientific Institute, Milano, Italy)

Symposium 3

Friday, October 20　15:10-17:20 No. 5 (Hall Building Hall B5(2), 5F)

Thrombosis that should be familiar with the hematologists

Chairs:	Hideo Wada (Department of Molecular and Laboratory Medicine, Mie University Graduate School, Japan)
	Masahiro Ieko (Internal Medicine, School of Dentistry, Health Sciences University of Hokkaido, Japan)

Thrombosis in multiple myeloma

Speaker:

Tomoko Narita (Department of Hematology & Oncology, Nagoya City University Graduate School, Japan)

Myeloproliferative neoplasms and thrombosis

Speaker:

Hidesaku Asakura (Department of Internal Medicine(III), Kanazawa University School of Medicine, Kanazawa, Japan)

Thrombosis in PNH in the era of Eculizumab

Speaker:

Jun-ichi Nishimura (Hem./Onc., Osaka Univ., Suita, Japan)

Antiphospholipid antibodies and thrombosis

Speaker:

Tatsuya Atsumi (Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Japan)

Characteristics of heparin-induced thrombocytopenia-associated thromboembolic events

Speaker:

Shigeki Miyata (Clinical Laboratory Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan)

Ⓔ Symposium 4

Saturday, October 21　9:00-11:10 No. 1 (Hall Building Hall C, 4F)

Cutting-edge of basic and clinical research for malignant lymphoma

Chairs:	Kunihiro Tsukasaki (Department of Hemato-Oncology, Saitama International Medical Center, Japan)
	Hirokazu Nagai (Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan)

Advances in the targeted treatment of diffuse large B cell lymphoma

Speaker:

Wyndham Wilson (National Cancer Institute, USA)

Microenvironment and immunity of peripheral T-cell lymphoma including AILT and ATLL

Speaker:

Koichi Ohshima (Department of Pathology, Kurume University, Japan)

Current and future management of NK/T-cell lymphoma

Speaker:

Motoko Yamaguchi (Dept. Hematol. Oncol., Mie Univ. Grad. Sch. Med., Tsu, Japan)

New horizons in the treatment of Hodgkin lymphoma

Speaker:

Andreas Engert (University Hospital of Cologne, Cologne, Germany)

Ⓔ Symposium 6

Saturday, October 21　14:50-17:00 No. 7 (Hall Building Hall D5, 5F)

New world of innate immunity: Novel ontogeny and functions

Chairs:	Toshio Kitamura (Div. of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Japan)
	Yoshio Katayama (Hematology, Kobe University Hospital, Japan)

Regulation of hematopoietic stem cells by C/EBPβ, a transcription factor required for emergency granulopoiesis

Speaker:

Hideyo Hirai (Transfusion Med. & Cell Therapy, Kyoto Univ., Kyoto, Japan)

Innate immune networks as regulators of the hematopoietic niche

Speaker:

Andres Hidalgo (Fundación CNIC, Madrid, Spain/Institute for Cardiovascular Prevention, Munich, Germany)

Functional diversity of various disorder-specific macrophage subtype

Speaker:

Takashi Satoh (Research Institute for Microbial Diseases, Osaka Univ., Osaka, Japan/ WPI IFReC, Osaka Univ., Osaka, Japan)

Identification of a human progenitor with strict monocyte differentiation potential: A counterpart of mouse cMoPs

Speaker:

Toshiaki Ohteki (Biodefense Res., Tokyo Medical and Dental Univ., Tokyo, Japan)

Development and functions of resident macrophages

Speaker:

Frederic Geissmann (Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

Symposium 8

Sunday, October 22　9:00-11:10 No. 5 (Hall Building Hall B5(2), 5F)

New frontier in genomic medicine for pediatric hematology/oncology

Chairs:	Keizo Horibe (Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan)
	Shouichi Ohga (Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Japan)

Diagnostic clinical target and exome sequencing for Diamond-Blackfan anemia in Japan

Speaker:

Tsutomu Toki (Pediatrics, Hirosaki Univ., Aomori, Japan)

Clinical sequencing in inherited bone marrow failure syndromes

Speaker:

Yusuke Okuno (Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Japan)

Recent advances in genetic diagnosis and therapeutic approach for primary immunodeficiency syndromes

Speaker:

Yoji Sasahara (Department of Pediatrics, Tohoku University Graduate School of Medicine, Japan)

Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact

Speaker:

Junko Takita (Pediatrics, The Univ. of Tokyo, Tokyo, Japan)

Ethical and social issues of clinical application of genomic technology

Speaker:

Kazuto Kato (Department of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, Japan)

Ⓔ Symposium 9

Sunday, October 22　13:20-15:30 No. 1 (Hall Building Hall C, 4F)

Myeloid neoplasia and clinical sequence

Chairs:	Seishi Ogawa (Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan)
	Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan)

Introduction to the 2016 revised WHO criteria for MPN

Speaker:

Kazuya Shimoda (Gastroenterology and Hematology, University of Miyazaki, Miyazaki, Japan)

Mechanism of mutant molecular chaperone-induced development of myeloproliferative neoplasms

Speaker:

Marito Araki (Dept. Transfus. Med. & Stem Cell Reg., Juntendo Univ., Tokyo, Japan)

Translating recent cancer genome discoveries to patient tailored clinical intervention protocols

Speaker:

Elli Papaemmanuil (Memorial Sloan Kettering Cancer Center, USA)

Clinical implications of clonal hematopoiesis

Speaker:

Rafael Bejar (Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, USA)

Somatic mutation in MDS and its effect on outcome

Speaker:

Tetsuichi Yoshizato (Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan)

Ⓔ Symposium 10

Sunday, October 22　13:20-15:30 No. 5 (Hall Building Hall B5(2), 5F)

GVHD: A bench-to-bedside update

Chairs:	Makoto Murata (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan)
	Junya Kanda (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan)

Impact of mismatched HLA on graft-versus-host disease in unrelated stem cell transplantation

Speaker:

Satoko Morishima (Endocrinology, Diabetes, Metabolism, Hematology, Rheumatology, Ryukyus Univ., Okinawa, Japan)

Immunogenetics of unrelated donor hematopoietic cell transplantation

Speaker:

Effie Wang Petersdorf (Fred Hutchinson Cancer Research Center, Seattle, WA, USA)

New insight into Treg homeostasis and GVHD in the era of peri-transplant immune modulation

Speaker:

Ken-ichi Matsuoka (Department of Hematology and Oncology, Okayama University, Okayama, Japan)

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources

Speaker:

Yoshihiro Inamoto (Division of HSCT, National Cancer Center Hospital, Tokyo, Japan)

ATG for prevention of chronic GvHD after allogeneic stem cell transplantation

Speaker:

Nicolaus Kröger (Stem Cell Transplantation, University Medical Center, Hamburg, Germany)

SHI (Socio-Hematology Issues) Symposium

SHI Symposium 1

Saturday, October 21　9:00-11:10 No. 3 (Hall Building Hall B7(2), 7F)

Clinical research's diverse challenges and future prospects

Chairs:	Yuzuru Kanakura (Dept. of Hematology and Oncology, Osaka Univ. Graduate Sch. of Medicine, Japan)
	Masafumi Taniwaki (Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Japan)

AMED mission for empowering translational sciences

Speaker:

Makoto Suematsu (Japan Agency for Medical Research and Development, Japan)

Progress in genomics and personalized medicine

Speaker:

Shinichi Mizuno (Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan)

Current situation and challenges of new drug approval in Japan: Focusing on the drugs for the treatment of hematological malignancies

Speaker:

Toyotaka Iguchi (Pharmaceuticals and Medical Devices Agency, Tokyo, Japan)

Measures to research misconduct

Speaker:

Toshio Kuroki (Japan Society for the Promotion of Science, Japan)

SHI Symposium 2

Saturday, October 21　14:50-17:00 No. 3 (Hall Building Hall B7(2), 7F)

Challenges and prospects for the introduction of new medical specialist system

Chairs:	Hideo Harigae (Department of Hematology and Rheumatology, Tohoku University Hospital, Japan)
	Michihide Tokuhira (Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan)

The dawn of general medicine as a specialty in Japan

Speaker:

Masayoshi Hashimoto (GIM, Saitama Med. Univ., Saitama, Japan)

How do we train and practice hematology and medical oncology in the United States: What a great combination that makes perfect sense

Speaker:

Hikaru Nakajima (DDivision of Hematology/Medical Oncology, St. Luke's University Hospital, Lewis Katz School of Medicine at Temple University, Bethlehem, PA, USA)

New program for trainee of internal medicine

Speaker:

Akihito Yokoyama (Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Japan)

Development of a new training program for the medical specialist in hematology

Speaker:

Hideo Harigae (Hematol. and Rheumatolo., Tohoku Univ., Sendai, Japan)

The present status of the new board certification system of medical specialties in Japan

Speaker:

Hirokuni Yoshimura (Japanese Medical Specialty Board, Japan)

SHI Symposium 3

Sunday, October 22　9:00-11:10 No. 6 (Hall Building Hall D7, 7F)

Current status and problems in at-home/palliative medical care for hematological malignancies

Chairs:	Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan)
	Koji Izutsu (National Cancer Center Hospital, Japan)

How to support the whole course of patients with hematological malignancy: Proposals from home care physician

Speaker:

Shohei Kawagoe (Aozora Clinic, Chiba, Japan)

Home medical care for hematological malignancies (from the standpoint of a home clinic)

Speaker:

Kota Ohashi (Totus Home Care Clinic, Japan/ Department of Hematology, National Cancer Center Hospital East, Chiba, Japan)

Home healthcare for the patients with hematological diseases in our institute

Speaker:

Satoshi Kayukawa (Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan)

Present status and issues concerning the medical care of hematological malignancies on remote islands

Speaker:

Tomoko Hata (Hematology, Atomic Bomb Disease Instituts, Nagasaki University, Nagasaki, Japan)

Current status and problem of palliative care for hematological malignancies

Speaker:

Naokuni Uike (Department of Palliative Care, Saga-Ken Medical Centre Koseikan, Saga, Japan)

SHI Symposium 4

Sunday, October 22　13:20-15:30 No. 7 (Hall Building Hall D5, 5F)

Building a career as a female hematologist: The path I've pursued and future prospects

Chairs:	Kinuko Mitani (Department of Hematology and Oncology, Dokkyo Medical University, Japan)
	Itaru Matsumura (Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan)

Building a career as a public officer

Speaker:

Hiroko Otsubo (Cabinet Secretariat, Government of Japan, Japan)

A novel therapeutic approach for adult T-cell leukemia/lymphoma

Speaker:

Youko Suehiro (Dept. Hematol. & Dept. Cell Therapy, Natl. Kyushu Cancer Center, Fukuoka, Japan)

Hematology, regenerative medicine, and me. As a female hematologist

Speaker:

Sachiko Ezoe (Hematol., Osaka Univ., Suita, Japan/ Dep. Environmental Space Infection Control, Osaka Univ., Suita, Japan)

Is it patient centricity?

Speaker:

Harumi Mukai (Medical, AbbVie GK, Tokyo, Japan)

Bridging between Japan and the US, and hematology and hematopathology

Speaker:

Mariko Yabe (Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

Translational science in hematology as a vocation: Physician-scientist training in US

Speaker:

Sawa Ito (Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, USA)

Special Educational Lecture/Educational Lecture

Educational Lecture　EL1-1

Friday, October 20　9:00-9:30 No. 2 (Hall Building Hall B7(1), 7F)

Chronic lymphocytic leukemia: Biology, disease progression, and current treatment strategies

Chair:	Sadao Aoki (Department of Pathophysiology, Niigata University of Pharmacy and Applied Life Sciences, Japan)
Speaker:	Takahiro Yano (Division of Hematology, Department of Internal Medicine, National Hospital Organization Tokyo Medical Center, Japan)

Educational Lecture　EL1-2

Friday, October 20　9:30-10:00 No. 2 (Hall Building Hall B7(1), 7F)

Initial treatment strategy for patients newly diagnosed with multiple myeloma

Chair:	Takaaki Chou (Niigata Cancer Center Hospital, Japan)
Speaker:	Hideo Yagi (Department of Hematology, Nara Hospital, Japan/Kindai University School of Medicine, Japan)

Educational Lecture　EL1-3

Friday, October 20　10:00-10:30 No. 2 (Hall Building Hall B7(1), 7F)

Therapeutic approach for relapsed/refractory multiple myeloma: The logic and practice

Chair:	Hirokazu Murakami (Gunma University Graduate School of Health Sciences, Japan)
Speaker:	Junya Kuroda (Division of Hematology & Oncology, Kyoto Prefectural University of Medicine, Japan)

Ⓔ Special Educational Lecture　SEL1-4

Friday, October 20　10:30-11:10 No. 2 (Hall Building Hall B7(1), 7F)

Novel therapeutic strategies for multiple myeloma

Chair:	Masafumi Taniwaki (Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Japan)
Speaker:	Shaji Kumar (Mayo Clinic, USA)

Educational Lecture　EL1-5

Friday, October 20　9:00-9:30 No. 3 (Hall Building Hall B7(2), 7F)

Molecular biology and treatment of CML

Chair:	Naoto Takahashi (Akita University, Hematology, Japan)
Speaker:	Shinya Kimura (Division of Hematology, Respiratory Medicine and Oncology, Saga University, Japan)

Educational Lecture　EL1-6

Friday, October 20　9:30-10:00 No. 3 (Hall Building Hall B7(2), 7F)

Current treatment strategies for newly diagnosed and relapsed APL

Chair:	Ryuzo Ohno (Aichi Cancer Center, Japan)
Speaker:	Nobuhiko Emi (Department of Hematology, Fujita Health University, Japan)

Educational Lecture　EL1-7

Friday, October 20　10:00-10:30 No. 3 (Hall Building Hall B7(2), 7F)

Treatment strategy for patients with Hodgkin lymphoma

Chair:	Kenichi Ishizawa (Department of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Japan)
Speaker:	Isao Yoshida (Department of Hematologic Oncology, NHO Shikoku Cancer Center, Japan)

Ⓔ Special Educational Lecture　SEL1-8

Friday, October 20　10:30-11:10 No. 3 (Hall Building Hall B7(2), 7F)

Therapeutic approach for T-cell lymphoma

Chair:	Kensei Tobinai (National Cancer Center Hospital, Japan)
Speaker:	Steven M. Horwitz (Memorial Sloan Kettering Cancer Center, USA)

Special Educational Lecture　SEL1-9

Friday, October 20　9:00-9:40 No. 4 (Hall Building Hall B5(1), 5F)

Epigenetic dysregulation in myelodysplastic syndromes

Chair:	Toshio Suda (National University of Singapore, Singapore/Kumamoto University, IRCMS, Japan)
Speaker:	Goro Sashida (International Research Center for Medical Science, Japan)

Special Educational Lecture　SEL1-10

Friday, October 20　9:40-10:20 No. 4 (Hall Building Hall B5(1), 5F)

Metabolic regulation specific to leukemia stem cells

Chair:	Kazuo Kitabayashi (National Cancer Center Research Institute, Japan)
Speaker:	Kazuhito Naka (Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan)

Special Educational Lecture　SEL1-11

Friday, October 20　10:20-11:00 No. 4 (Hall Building Hall B5(1), 5F)

Sequential acquisition of mutations in myelodysplastic syndromes

Chair:	Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan)
Speaker:	Hideki Makishima (Department of Pathology and Tumor Biology, Kyoto University, Japan)

Educational Lecture　EL1-12

Friday, October 20　15:10-15:40 No. 2 (Hall Building Hall B7(1), 7F)

Familial hematological malignancies

Chair:	Tatsutoshi Nakahata (Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)
Speaker:	Atsushi Manabe (Department of Pediatrics, St. Luke's International Hospital, Japan)

Educational Lecture　EL1-13

Friday, October 20　15:40-16:10 No. 2 (Hall Building Hall B7(1), 7F)

Acute leukemia in adolescents and young adults

Chair:	Kanji Sugita (Department of Pediatrics, University of Yamanashi, Japan)
Speaker:	Daisuke Tomizawa (Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Japan)

Educational Lecture　EL1-14

Friday, October 20　16:10-16:40 No. 2 (Hall Building Hall B7(1), 7F)

Recent progress in the treatment of pediatric lymphoma in Japan

Chair:	Masao Kobayashi (Dept. of Pediatrics, Hiroshima University, Graduate School of Biomedical & Health Sciences, Japan)
Speaker:	Tetsuo Mitsui (Yamagata University Hospital, Japan)

Ⓔ Special Educational Lecture　SEL1-15

Friday, October 20　16:40-17:20 No. 2 (Hall Building Hall B7(1), 7F)

Genomic basis and treatment of Waldenstrom's macroglobulinemia

Chair:	Kiyohiko Hatake (Japanese Foundation for Cancer Research Cancer Institute Hospital, Japan)
Speaker:	Steven P. Treon (Dana-Farber Cancer Institute, Boston, MA, USA)

Educational Lecture　EL1-16

Friday, October 20　15:10-15:40 No. 3 (Hall Building Hall B7(2), 7F)

Allogeneic hematopoietic stem cell transplantation using ATG: Prophylaxis and treatment

Chair:	Taizo Tasaka (Saitama Medical Center, Transfusion Medicine, Japan)
Speaker:	Nobuhiro Nishio (Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Japan)

Educational Lecture　EL1-17

Friday, October 20　15:40-16:10 No. 3 (Hall Building Hall B7(2), 7F)

Long-term follow-up clinics after hematopoietic cell transplantation: The needs and challenges of LTFU in Japan

Chair:	Shuichi Taniguchi (Department of Hematology, Toranomon Hospital, Japan)
Speaker:	Saiko Kurosawa (National Cancer Center Hospital, Japan)

Educational Lecture　EL1-18

Friday, October 20　16:10-16:40 No. 3 (Hall Building Hall B7(2), 7F)

HLA-haploidentical transplantation with post-transplant cyclophosphamide

Chair:	Yoshinobu Maeda (Okayama University Hospital, Japan)
Speaker:	Junichi Sugita (Department of Hematology, Hokkaido University Graduate School of Medicine, Japan)

Special Educational Lecture　SEL1-19

Friday, October 20　16:40-17:20 No. 3 (Hall Building Hall B7(2), 7F)

Hematopoietic stem cell transplantation in the era of molecular targeted therapy

Chair:	Shinichiro Okamoto (Department of Medicine (Hematology), Keio University School of Medicine, Japan)
Speaker:	Shin Mineishi (Penn State Hershey Medical Center, USA)

Educational Lecture　EL2-1

Saturday, October 21　9:00-9:30 No. 2 (Hall Building Hall B7(1), 7F)

Frontline treatment of AML in adults

Chair:	Kazunori Ohnishi (Japan Red Cross Aichi Blood Center, Japan)
Speaker:	Toshihiro Miyamoto (Department of Medicine and Biosystemic Science Faculty of Medicine, Kyushu University, Japan)

Educational Lecture　EL2-2

Saturday, October 21　9:30-10:00 No. 2 (Hall Building Hall B7(1), 7F)

Treatment of relapsed or refractory acute myeloid leukemia

Chair:	Kensuke Usuki (NTT Medical Center Tokyo, Japan)
Speaker:	Hikaru Kobayashi (Department of Hematology, Nagano Red Cross Hospital, Japan)

Educational Lecture　EL2-3

Saturday, October 21　10:00-10:30 No. 2 (Hall Building Hall B7(1), 7F)

Treatment of elderly patients with acute myeloid leukemia

Chair:	Takanori Ueda (University of Fukui, Japan)
Speaker:	Tomonori Nakazato (Department of Hematology, Yokohama Municipal Citizen's Hospital, Japan)

Special Educational Lecture　SEL2-4

Saturday, October 21　10:30-11:10 No. 2 (Hall Building Hall B7(1), 7F)

Clinical sequencing in leukemia with the assistance of artificial intelligence

Chair:	Shuichi Miyawaki (Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Japan)
Speaker:	Arinobu Tojo (Division of Molecular Therapy, Advanced Clinical Research Center Institute of Medical Science, The University of Tokyo, Japan)

Educational Lecture　EL2-5

Saturday, October 21　9:00-9:30 No. 5 (Hall Building Hall B5(2), 5F)

Future prospects of hemostatic treatment for hemophilia patients

Chair:	Akira Yoshioka (Nara Medical University, Japan)
Speaker:	Keiji Nogami (Department of Pediatrics, Nara Medical University, Japan)

Educational Lecture　EL2-6

Saturday, October 21　9:30-10:00 No. 5 (Hall Building Hall B5(2), 5F)

New developments in treatment modalities of thrombotic thrombocytopenic purpura

Chair:	Yoji Ishida (Iwate Medical University School of Medicine, Japan)
Speaker:	Masanori Matsumoto (Department of Blood Transfusion Medicine, Nara Medical University, Japan)

Educational Lecture　EL2-7

Saturday, October 21　10:00-10:30 No. 5 (Hall Building Hall B5(2), 5F)

Patient blood management and transfusion therapy for hemostasis

Chair:	Junki Takamatsu (Japanese Red Cross Tokai-Hokuriku Block Blood Center, Japan)
Speaker:	Koji Yamamoto (Department of Transfusion Medicine and Cell Therapy Saitama Medical Center, Saitama Medical University, Japan)

Special Educational Lecture　SEL2-8

Saturday, October 21　10:30-11:10 No. 5 (Hall Building Hall B5(2), 5F)

Development of iPS cell-derived blood products and production guidelines

Chair:	Shigetaka Asano (Waseda University, Japan (Kobe University, Japan))
Speaker:	Naoshi Sugimoto (Department of Clinical Application Center for iPS Cell Research and Application, Kyoto University, Japan)

Educational Lecture　EL2-9

Saturday, October 21　14:50-15:20 No. 2 (Hall Building Hall B7(1), 7F)

Effect of mutation on diagnosis, risk stratification, and treatment decisions in Philadelphia-negative myeloproliferative neoplasms

Chair:	Kazuma Ohyashiki (Department of Hematology, Tokyo Medical University, Japan)
Speaker:	Keita Kirito (Department of Hematology & Oncology, University of Yamanashi, Japan)

Educational Lecture　EL2-10

Saturday, October 21　15:20-15:50 No. 2 (Hall Building Hall B7(1), 7F)

MDS: Recent progress in molecular pathogenesis and clinical aspects

Chair:	Kiyoshi Ando (Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Japan)
Speaker:	Hironori Harada (Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, Japan)

Educational Lecture　EL2-11

Saturday, October 21　15:50-16:20 No. 2 (Hall Building Hall B7(1), 7F)

Treatment for myelodysplastic syndrome-with a focus on the low-risk group

Chair:	Koiti Inokuchi (Nippon Medical School, Japan)
Speaker:	Akihiko Gotoh (Department of Hematology, Juntendo University School of Medicine, Japan)

Ⓔ Special Educational Lecture　SEL2-12

Saturday, October 21　16:20-17:00 No. 2 (Hall Building Hall B7(1), 7F)

MDS stem cell behavior: Can it predict clinical outcomes?

Chair:	Masao Tomonaga (Junshin-Seibokai Nagasaki Atomic Bomb Nursing Home, Japan)
Speaker:	Stephen D. Nimer (Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, USA)

Educational Lecture　EL2-13

Saturday, October 21　14:50-15:20 No. 4 (Hall Building Hall B5(1), 5F)

The cutting edge of aplastic anemia treatment

Chair:	Masami Bessho (Department of Hematology, Saitama Medical University, Japan)
Speaker:	Naoshi Obara (Department of Hematology, University of Tsukuba Faculty of Medicine, Japan)

Educational Lecture　EL2-14

Saturday, October 21　15:20-15:50 No. 4 (Hall Building Hall B5(1), 5F)

The present situation and problems of therapy for PNH

Chair:	Shinji Nakao (Graduate School of Medical Sciences, Kanazawa University, Japan)
Speaker:	Hideyoshi Noji (Department of Hematology/Department of Medical Oncology, Fukushima Medical University, Japan)

Educational Lecture　EL2-15

Saturday, October 21　15:50-16:20 No. 4 (Hall Building Hall B5(1), 5F)

Pathogenesis and treatment of anemia in chronic kidney disease

Chair:	Akio Urabe (NTT Medical Center Tokyo, Japan)
Speaker:	Masaomi Nangaku (Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan)

Educational Lecture　EL2-16

Saturday, October 21　16:20-16:50 No. 4 (Hall Building Hall B5(1), 5F)

Progress in iron metabolism research

Chair:	Naoyuki Katayama (Department of Hematology and Oncology, Mie Graduate School of Medicne, Japan)
Speaker:	Hiroshi Kawabata (Department of Hematology and Immunology, Kanazawa Medical University, Japan)

Special Educational Lecture　SEL2-17

Saturday, October 21　14:50-15:30 No. 5 (Hall Building Hall B5(2), 5F)

Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells

Chair:	Mineo Kurokawa (Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Japan)
Speaker:	Yoshikane Kikushige (Department of Medicine and Biosystemic Science, Kyushu University, Japan)

Special Educational Lecture　SEL2-18

Saturday, October 21　15:30-16:10 No. 5 (Hall Building Hall B5(2), 5F)

Abnormal hematopoiesis and hematopoietic stem cell niche

Chair:	Atsushi Hirao (Division of Molecular Genetics, Cancer Research Institute of Kanazawa University, Japan)
Speaker:	Keiyo Takubo (Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Japan)

Special Educational Lecture　SEL2-19

Saturday, October 21　16:10-17:00 No. 5 (Hall Building Hall B5(2), 5F)

Autophagy: Basic research and clinical implication

Chair:	Ryuzo Ueda (Department of Tumor Immunology, Aichi Medical University School of Medicine, Japan)
Speaker:	Noboru Mizushima (Department of Biochemistry and Molecular Biology, Graduate School of Medicine, The University of Tokyo, Japan)

Educational Lecture　EL3-1

Sunday, October 22　9:00-9:30 No. 2 (Hall Building Hall B7(1), 7F)

Current treatment of adult acute lymphoblastic leukemia

Chair:	Noriko Usui (Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, Japan)
Speaker:	Shin Fujisawa (Department of Hematology, Yokohama City University Medical Center, Japan)

Educational Lecture　EL3-2

Sunday, October 22　9:30-10:00 No. 2 (Hall Building Hall B7(1), 7F)

Treatment of relapsed or refractory acute lymphoblastic leukemia

Chair:	Yoshinobu Kanda (Division of Hematology, Department of Medicine, Jichi Medical University, Japan/Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan)
Speaker:	Kiyotoshi Imai (Department of Hematology, Sapporo Hokuyu Hospital, Japan)

Educational Lecture　EL3-3

Sunday, October 22　10:00-10:30 No. 2 (Hall Building Hall B7(1), 7F)

Molecular pathogenesis and its therapeutic implication for ATL

Chair:	Akifumi Takaori-Kondo (Graduate School of Medicine, Kyoto University, Japan)
Speaker:	Kenji Ishitsuka (Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan)

Special Educational Lecture　SEL3-4

Sunday, October 22　10:30-11:10 No. 2 (Hall Building Hall B7(1), 7F)

Current status of ATL research: Efforts for prevention and precision medicine for ATL

Chair:	Atae Utsunomiya (Imamura General Hospital, Japan)
Speaker:	Toshiki Watanabe (Department of Advanced Medical Innovation, Graduate School of Medicine, St. Marianna University School of Medicine, Japan)

Special Educational Lecture　SEL3-5

Sunday, October 22　9:00-9:40 No. 3 (Hall Building Hall B7(2), 7F)

Recent topics in IMiDs and cereblon

Chair:	Kenzaburo Tani (The Institute of Medical Science, The University of Tokyo, Japan)
Speaker:	Hiroshi Handa (Department of Nanoparticle Translational Research, Tokyo Medical University, Japan)

Special Educational Lecture　SEL3-6

Sunday, October 22　9:40-10:20 No. 3 (Hall Building Hall B7(2), 7F)

Genetically modified T cell therapy for hematological malignancies

Chair:	Keiya Ozawa (Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Japan)
Speaker:	Yoshiyuki Takahashi (Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan)

Ⓔ Special Educational Lecture　SEL3-7

Sunday, October 22　10:20-11:10 No. 3 (Hall Building Hall B7(2), 7F)

Acute Promyelocytic leukemia: A model of personalized medicine

Chair:	Tomoki Naoe (National Hospital Organization Nagoya Medical Center, Japan)
Speaker:	Christine Chomienne (Institut Universitaire d'Hematologie, Hopital Saint Louis, France)

Educational Lecture　EL3-8

Sunday, October 22　13:20-13:50 No. 2 (Hall Building Hall B7(1), 7F)

Management strategy for follicular lymphoma

Chair:	Tomomitsu Hotta (National Cancer Center, Japan/NHO Nagoya Medical Center, Japan)
Speaker:	Noriko Fukuhara (Department of Hematology and Rheumatology, Tohoku University Hospital, Japan)

Educational Lecture　EL3-9

Sunday, October 22　13:50-14:20 No. 2 (Hall Building Hall B7(1), 7F)

Treatment for mantle cell lymphoma

Chair:	Kazuhito Yamamoto (Department of Hematology and Cell Therapy, Aichi Cancer Center, Japan)
Speaker:	Koji Izutsu (National Cancer Center Hospital, Japan)

Educational Lecture　EL3-10

Sunday, October 22　14:20-14:50 No. 2 (Hall Building Hall B7(1), 7F)

Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma

Chair:	Junji Suzumiya (Shimane University Hospital Cancer Center, Japan)
Speaker:	Kazuyuki Shimada (Department of Hematology, Nagoya University Hospital, Japan)

Special Educational Lecture　SEL3-11

Sunday, October 22　14:50-15:30 No. 2 (Hall Building Hall B7(1), 7F)

PD-1 blockade therapy in lymphoid malignancies

Chair:	Masaki Yasukawa (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan)
Speaker:	Momoko Nishikori (Department of Hematology/Oncology, Kyoto University, Japan)

Educational Lecture　EL3-12

Sunday, October 22　13:20-13:50 No. 3 (Hall Building Hall B7(2), 7F)

Idiopathic thrombosis

Chair:	Yohko Kawai (International University of Health and Welfare, Japan)
Speaker:	Hiroko Tsuda (Graduate School of Health and Nutrition Sciences, Nakamura Gakuen University, Japan)

Educational Lecture　EL3-13

Sunday, October 22　13:50-14:20 No. 3 (Hall Building Hall B7(2), 7F)

Basic concept for evaluating coagulation and fibrinolysis data

Chair:	Midori Shima (Department of Pediatrics, Nara Medical University, Japan)
Speaker:	Teruto Hashiguchi (Department of Laboratory and Vascular Medicine, Graduate School of Medical and Dental Sciences Kagoshima University, Japan)

Educational Lecture　EL3-14

Sunday, October 22　14:20-14:50 No. 3 (Hall Building Hall B7(2), 7F)

Myeloid neoplasms in the World Health Organization 2016 classification

Chair:	Kazutaka Kuriyama (Nagasaki Harbor Medical Center, Japan)
Speaker:	Norio Asou (Department of Hematology, International Medical Center, Saitama Medical University, Japan)

Educational Lecture　EL3-15

Sunday, October 22　14:50-15:20 No. 3 (Hall Building Hall B7(2), 7F)

2016 revision of the WHO classification of lymphoid neoplasms

Chair:	Ikuo Miura (Department of Internal Medicine, Division of Hematology and Oncology, St. Marianna University School of Medicine, Japan)
Speaker:	Jun-ichi Tamaru (Department of Pathology, Saitama Medical Center Saitama Medical University, Japan)

Special Educational Lecture　SEL3-16

Sunday, October 22　13:20-14:10 No. 4 (Hall Building Hall B5(1), 5F)

Regenerative medicine using iPS cells

Chair:	Yasuo Ikeda (Waseda University, Japan)
Speaker:	Hideyuki Okano (Department of Physiology, Keio University School of Medicine, Japan)

Corporate Seminar

Luncheon Seminar　LS1-2

Friday, October 20　12:15-13:00 No. 2 (Hall Building Hall B7(1), 7F)

Emerging treatment options for Relapsed or refractory Hodgkin lymphoma

Sponsor: ONO PHARMACEUTICAL CO., LTD. / Bristol-Myers Squibb K.K.

Chair:	Hirokazu Nagai (Department of Hematology and Oncology Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center)
Speaker:	Wataru Munakata (Department of Hematology, National Cancer Center Hospital)

Luncheon Seminar　LS1-3

Friday, October 20　12:15-13:00 No. 3 (Hall Building Hall B7(2), 7F)

Subcutaneous Immunoglobulin Therapy for Primary Immunodeficiency

Sponsor: CSL Behring K.K.

Chair:	Kiyoshi Kitamura (School of Medicine, International University of Health and Welfare)
Speaker:	Masao Kobayashi (Hiroshima University Graduate School of Biomedical & Health Sciences, Pediatrics)

Ⓔ Luncheon Seminar　LS1-4

Friday, October 20　12:15-13:00 No. 4 (Hall Building Hall B5(1), 5F)

MDS: how close are we to a precision medicine approach?

Sponsor: Kyowa Hakko Kirin Co., Ltd.

Chair:	Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)
Speaker:	Stephen D. Nimer (Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine)

Luncheon Seminar　LS1-5

Friday, October 20　12:15-13:00 No. 5 (Hall Building Hall B5(2), 5F)

Antibody Therapy for Multiple Myeloma -Insights into the optimal use of therapeutic antibodies from basic research-

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Masafumi Taniwaki (Center for Molecular Diagnostics and Therapeutics　Kyoto Prefectural University of Medicine)
Speaker:	Yusuke Furukawa (Center for Molecular Medicine, Jichi Medical University)

Luncheon Seminar　LS1-6

Friday, October 20　12:15-13:00 No. 6 (Hall Building Hall D7, 7F)

Toward diagnosis improvement for MPN

Sponsor: Novartis Pharma K.K.

Chair:	Keita Kirito (Department of Hematology and Oncology, University of Yamanashi)
Speaker:	Masafumi Ito (Department of Pathology, Japanese Red Cross Nagoya Daiichi Hospital)

Luncheon Seminar　LS1-7

Friday, October 20　12:15-13:00 No. 7 (Hall Building Hall D5, 5F)

Immunotherapy in multiple myeloma: present and future

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Itaru Matsumura (Department of Hematology & Rheumatology Kindai University Faculty of Medicine)
Speaker:	Teru Hideshima (Jerome Lipper Myeloma Center Department of Medical Oncology Dana-Farber Cancer Institute)

Luncheon Seminar　LS1-8

Friday, October 20　12:15-13:00 No. 8 (Hall Building Hall D1, 1F)

Personalized haemophilia therapy can be a reality tomorrow -Customizing treatment to meet the changes in the patient’s lifestyle-

Sponsor: Pfizer Japan Inc.

Chair:	Masashi Taki (Department of Pediatrics, St. Marianna University School of Medicine Yokohama City Seibu Hospital)
Speaker:	Masato Bingo (Department of Laboratory Medicine, Tokyo Medical University)

Ⓔ Luncheon Seminar　LS1-9

Friday, October 20　12:15-13:00 No. 9 (Glass Building G402, 4F)

Genomic and Treatment Advances in Waldenström's Macroglobulinemia

Sponsor: SymBio Pharmaceuticals Limited/ Eisai Co.,Ltd.

Chair:	Michihide Tokuhira (Department of Hematology, Saitama Medical Center, Saitama Medical University)
Speaker:	Steven P. Treon (Bing Center for Waldenström's Macroglobulinemia, Department of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School)

Luncheon Seminar　LS1-10

Friday, October 20　12:15-13:00 No. 10 (Glass Building G409, 4F)

ImmunoOncology :Current Status and Future Perspective

Sponsor: MSD K.K.

Chair:	Takaaki Chou (Department of Internal Medicine, Niigata Cancer Center Hospital)
Speaker:	Yutaka Kawakami (Division of Celluar Signaling, Institute for Advanced Medical Research, Keio University School of Medicine)

Luncheon Seminar　LS1-11

Friday, October 20　12:15-13:00 No. 11 (Glass Building G502, 5F)

Treatment strategy for transplant-ineligible multiple myeloma

Sponsor: Fuji Pharma Co.,Ltd.

Chair:	Kiyotoshi Imai (Department of Hematology, Sapporo Hokuyu Hospital)
Speaker:	Shigeki Ito (Department of Clinical Oncology, Iwate Medical University School of Medicine)

Luncheon Seminar　LS1-12

Friday, October 20　12:15-13:00 No. 12 (Glass Building G510, 5F)

Create a new mindset for Essential thrombocythemia(ET) ～medical practice based on precise diagnosis and treatment algorism～

Sponsor: Shire Japan KK

Chair:	Norio Komatsu (Department of Hematology, Juntendo University School of Medicine)
Speaker:	Kazuya Shimoda (Gastroenterlogy and Hematology, Faculty of Medicine, University of Miyazaki)

Ⓔ Luncheon Seminar　LS1-13

Friday, October 20　12:15-13:00 No. 13 (Glass Building G602, 6F)

New Horizons in the Treatment of Hodgkin Lymphoma

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Kazuhito Yamamoto (Department of Hematology and Cell Therapy, Aichi Cancer Center)
Speaker:	Andreas Engert (German Hodgkin Study Group (GHSG), Department of Internal Medicine I, University Hospital of Cologne)

Luncheon Seminar　LS1-14

Friday, October 20　12:15-13:00 No. 14 (Glass Building G610, 6F)

Progress in the pathology and management for myeloma bone disease

Sponsor: Daiichi Sankyo Co., Ltd.

Chair:	Hiroshi Kosugi (Department of Hematology, Ogaki Municipal Hospital)
Speaker:	Masahiro Abe (Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School)

Luncheon Seminar　LS1-15

Friday, October 20　12:15-13:00 No. 15 (Glass Building G701, 7F)

Prophylaxis and treatment of invasive fungal infections in patients with hematologic diseases

Sponsor: Astellas Pharma Inc.

Chair:	Yoshinobu Kanda (Division of Hematology, Jichi Medical University)
Speaker:	Fumihiko Nakamura (Department of Hematology, National Center for Global Health and Medicine)

Industry Session　IS1

Friday, October 20　13:50-14:50 No. 11 (Glass Building G502, 5F)

Using medical Big Data in the clinical setting!　-Future prospects from experience participating in an infrastructure development project for a medical information database-

Sponsor: Chugai Pharmaceutical Co., Ltd.

Speaker:

Kotonari Aoki (Real World Data Science Department, Chugai Pharmaceutical. Co., Ltd.)

Ⓔ Industry Session　IS2

Friday, October 20　13:50-14:20 No. 12 (Glass Building G510, 5F)

The Positioning of Daratumumab in Relapsed/Refractory Multiple Myeloma (rrMM) in Clinical Practices

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Takaaki Hirai (Group Manager of Hematology Group, Department of Oncology 2, Medical Affairs Division, Janssenn Pharmaceutical K.K.)
Speaker:	Torben Plesner (University of Southern Denmark Institute of Regional Health Science Department of Hematology Section of Internal Medicine Vejle Hospital)

Industry Session　IS3

Friday, October 20　14:20-14:50 No. 12 (Glass Building G510, 5F)

Guide supporting method and management of adverse events for patients with multiple myeloma in the era of novel agents

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:	Tomohiko Kamimura (Department of Hematology, Harasanshin Hospital, Fukuoka / Fukuoka Blood and Marrow Transplantation Group (FBMTG))
Speaker:	Noriko Yokota (Department of Nursing, Harasanshin Hospital, Fukuoka(Certified Nurse in Cancer Chemotherapy Nursing) / Fukuoka Blood and Marrow Transplantation Group (FBMTG))

Morning Seminar　MS2-2

Saturday, October 21　8:00-8:45 No. 2 (Hall Building Hall B7(1), 7F)

Lymphoma Diagnosis Oriented for Precision Medicine, From Prognosis to Prediction

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:	Tadashi Yoshino (Department of Pathology, Okayama University Medical School)
Malignant lymphoma update : identification of nodal indolent T-cell disease
Speaker:	Shigeo Nakamura (Pathology and Laboratory Medicine, Nagoya University Graduate School of Medicine)
Microenvironment and immunity-PD-1/PD-L1 expression-
Speaker:	Kouichi Ohshima (Department of Pathology, Kurume University)

Morning Seminar　MS2-3

Saturday, October 21　8:00-8:45 No. 3 (Hall Building Hall B7(2), 7F)

Immunological Approach in the treatment of Multiple Myeloma

Sponsor: Celgene K.K.

Chair:	Yasushi Takamatsu (Fukuoka University Hospital　Division of Medical Oncology, Hematology, and Infectious diseases)
Speaker:	Shotaro Hagiwara (Department of Hematology, Tokyo Women's Medical University)

Morning Seminar　MS2-4

Saturday, October 21　8:00-8:45 No. 4 (Hall Building Hall B5(1), 5F)

Current treatment strategies for B-cell lymphoma

Sponsor: Kyowa Hakko Kirin Co., Ltd.

Chair:	Noriko Usui (The Jikei University School of Medicine Department of Transfusion Medicine)
Speaker:	Noriko Fukuhara (Department of Hematology and Rheumatology Tohoku University Hospital)

Morning Seminar　MS2-5

Saturday, October 21　8:00-8:45 No. 5 (Hall Building Hall B5(2), 5F)

Function of BTK in B cell malignancy～Efficacy of molecular target therapy from the viewpoint of basic research～

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Kenichi Ishizawa (Department of Hematology and Cell Therapy, Yamagata University Faculty of Medicine)
Speaker:	Ai Kotani (Department of Hematology and Oncology Tokai University, School of Medicine)

Morning Seminar　MS2-6

Saturday, October 21　8:00-8:45 No. 6 (Hall Building Hall D7, 7F)

A New Era in the Treatment of Aplastic Anemia

Sponsor: Novartis Pharma K.K.

Chair:	Keiya Ozawa (Division of Genetic Therapeutics, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo)
Speaker:	Shinji Nakao (Department of Hematology and Pulmonary Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University)

Morning Seminar　MS2-7

Saturday, October 21　8:00-8:45 No. 7 (Hall Building Hall D5, 5F)

Management of infectious disease after haematopoietic stem cell transplantation

Sponsor: MSD K.K.

Chair:	Shuichi Taniguchi (Department of Hematology, Toranomon Hospital)
Management of invasive fungal infection after HSCT
Speaker:	Toshihiro Miyamoto (Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University Graduate School of Medicine, Fukuoka, Japan)
Management of viral infections after HSCT
Speaker:	Katsuto Takenaka (Division of Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital)

Morning Seminar　MS2-9

Saturday, October 21　8:00-8:45 No. 9 (Glass Building G402, 4F)

Acute Myeloid Leukemia Treatment- Ara-C/DNR to Antibody Drug Conjugate-

Sponsor: Pfizer Japan Inc.

Chair:	Koji Nagafuji (Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine)
Speaker:	Takahiro Yamauchi (Hematology and Oncology, First Department of Internal Medicine, General Medicine, Faculty of Medical Science, University of Fukui)

Morning Seminar　MS2-10

Saturday, October 21　8:00-8:45 No. 10 (Glass Building G409, 4F)

Current findings of conditioning regimen for HSCT

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:	Shingo Yano (Division of Clinical Oncology/Hematology, The Jikei University School of Medicine)
Speaker:	Tadakazu Kondo (Department of hematology/oncology, Kyoto University)

Morning Seminar　MS2-11

Saturday, October 21　8:00-8:45 No. 11 (Glass Building G502, 5F)

Hepatitis B Virus Reactivation during and after antineoplastic chemotherapy and/or immunosuppressive therapy

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Akifumi Takaori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
Speaker:	Satoshi Mochida (Department of Gastroenterology & Hepatology, Saitama Medical University)

Morning Seminar　MS2-12

Saturday, October 21　8:00-8:45 No. 12 (Glass Building G510, 5F)

Suspecting Gaucher Disease in Daily Clinical Practices -The Basics and Diagnostic Tips-

Sponsor: Shire Japan KK

Chair:	Reiko Watanabe (Department of Hematology, Saitama Medical Center, Saitama Medical University)
Speaker:	Kazuya Tsuboi (LSD Center and Hematology, Nagoya Central Hospital)

Morning Seminar　MS2-13

Saturday, October 21　8:00-8:45 No. 13 (Glass Building G602, 6F)

Current strategies for treatment of relapsed/refractory multiple myeloma

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:	Kenshi Suzuki (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)
Speaker:	Hideto Tamura (Division of Hematology, Department of Medicine, Nippon Medical School)

Morning Seminar　MS2-14

Saturday, October 21　8:00-8:45 No. 14 (Glass Building G610, 6F)

Update of treatment strategy for relapsed or refractory PTCL

Sponsor: mundipharma K.K.

Chair:	Masataka Okamoto (Fujita Health University, Department of Hematology)
Speaker:	Dai Maruyama (National Cancer Center Hospital, Department of Hematology)

Ⓔ Luncheon Seminar　LS2-2

Saturday, October 21　12:15-13:00 No. 2 (Hall Building Hall B7(1), 7F)

Management of Multiple Myeloma: The Changing Paradigm

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Chiaki Nakaseko (Department of Hematology, International University of Health and Welfare School of Medicine)
Speaker:	Shaji K Kumar (Division of Hematology, Mayo Clinic, Rochester, MN)

Ⓔ Luncheon Seminar　LS2-3

Saturday, October 21　12:15-13:00 No. 3 (Hall Building Hall B7(2), 7F)

Treating PTCL: from Multi-drug Regimens to Novel Single Agents

Sponsor: Celgene K.K.

Chair:	Kiyoshi Ando (Tokai University School of Medicine　Department of Hematology and Oncology)
Speaker:	Steven M. Horwitz (Memorial Sloan Kettering Cancer Center, USA)

Ⓔ Luncheon Seminar　LS2-4

Saturday, October 21　12:15-13:00 No. 4 (Hall Building Hall B5(1), 5F)

The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes

Sponsor: NIPPON SHINYAKU CO., LTD.

Chair:	Shigeru Chiba (Department of Hematology, Faculty of Medicine, University of Tsukuba)
Speaker:	Rafael Bejar (UC San Diego Moores Cancer Center, Division of Hematology and Oncology)

Ⓔ Luncheon Seminar　LS2-5

Saturday, October 21　12:15-13:00 No. 5 (Hall Building Hall B5(2), 5F)

Treatment Strategy for Relapsed And Refractory Multiple Myeloma

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Shinsuke Iida (Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)
Speaker:	Henk M. Lokhorst (Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands)

Ⓔ Luncheon Seminar　LS2-6

Saturday, October 21　12:15-13:00 No. 6 (Hall Building Hall D7, 7F)

What Japanese Hematologists Need to Know in Chronic Myeloid Leukemia in 2018– Message from an ELN Expert Panel Member

Sponsor: Novartis Pharma K.K.

Chair:	Arinobu Tojo (Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo)
Speaker:	François-Xavier Mahon (Institut Bergonié, France)

Luncheon Seminar　LS2-7

Saturday, October 21　12:15-13:00 No. 7 (Hall Building Hall D5, 5F)

Clinical roles of Rituximab for chronic ITP

Sponsor: Zenyaku Kogyo Co., Ltd.

Chair:	Kingo Fujimura (Faculty of Nursing, Department of Nursing, Yasuda Women's University)
Speaker:	Yoshitaka Miyakawa (Department of General Internal Medicine, Center of Thrombosis and Hemostasis, Saitama Medical University Hospital)

Luncheon Seminar　LS2-8

Saturday, October 21　12:15-13:00 No. 8 (Hall Building Hall D1, 1F)

PNH Clinical Reference Guide Update and future treatment

Sponsor: Alexion Pharma G.K.

Chair:	Haruhiko Ninomiya (University of Tsukuba)
Speaker:	Junichi Nishimura (Osaka University Graduate School of Medicine)

Luncheon Seminar　LS2-9

Saturday, October 21　12:15-13:00 No. 9 (Glass Building G402, 4F)

Updates in the management of CML

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Yoshinobu Maeda (Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences Department of Hematology, Oncology, Allergy and Respiratory Medicine)
Speaker:	Tetsuzo Tauchi (Department of Hematology, Tokyo Medical University Hospital)

Luncheon Seminar　LS2-10

Saturday, October 21　12:15-13:00 No. 10 (Glass Building G409, 4F)

Risk management of Tumor lysis syndrome

Sponsor: Sanofi K.K.

Chair:	Shin Fujisawa (Department of Hematology, Yokohama City University Medical Center)
Tumor lysis syndrome management
Speaker:	Nobuhiro Tsukada (Division of Hematology, Japanese Red Cross Medical Center)
Add the viewpoint of the pharmacist! Tumor lysis syndrome management
Speaker:	Maki Nemoto (Department of Pharmacy, Cancer Institute Hospital, JFCR)

Ⓔ Luncheon Seminar　LS2-11

Saturday, October 21　12:15-13:00 No. 11 (Glass Building G502, 5F)

Treatment Strategy for Indolent Lymphoma

Sponsor: SymBio Pharmaceuticals Limited/ Eisai Co.,Ltd.

Chair:	Junji Suzumiya (Shimane University Hospital Cancer Center・Oncology/Hematology)
Speaker:	Mathias J. Rummel (The Department for Hematology at the Clinic for Hematology and Medical Oncology at the Justus-Liebig University-Hospital)

Luncheon Seminar　LS2-12

Saturday, October 21　12:15-13:00 No. 12 (Glass Building G510, 5F)

Proper Use of Antibiotics - Strategies to prevent emergence of drug-resistant bacteria while using broad spectrum antibiotics -

Sponsor: SHIONOGI & CO., LTD.

Chair:	Hideaki Nakajima (Department of Stem Cell and Immune Regulation,Yokohama City University Graduate School of Medicine)
Speaker:	Katsuji Teruya (AIDS Clinical Center (ACC), Center Hospital of the National Center for Global Health and Medicine)

Luncheon Seminar　LS2-13

Saturday, October 21　12:15-13:00 No. 13 (Glass Building G602, 6F)

Guidelines for clinical practice of hematological malignancies revised edition UP TO DATE~ Focusing on APL-DIC treatment ~

Sponsor: Asahi Kasei Pharma Corporation

Chair:	Kazuo Kawasugi (Faculty of Medical Technology, Teikyo University)
Speaker:	Hiroyuki Fujita (Department of Hematology, Saiseikai Yokohama Nanbu Hospital)

Luncheon Seminar　LS2-14

Saturday, October 21　12:15-13:00 No. 14 (Glass Building G610, 6F)

New Horizon of Hemophilia A Treatment ― How EHL Changed the Patients Life ―

Sponsor: Baxalta Japan Ltd.

Chair:	Teruhisa Fujii (Division of Blood Transfusion, Hiroshima University Hospital)
Speaker:	Nobuaki Suzuki (Department of Transfusion Medicine, Nagoya University Hospital)

Luncheon Seminar　LS2-15

Saturday, October 21　12:15-13:00 No. 15 (Glass Building G701, 7F)

Recent advance in the treatment of mature T-cell lymphoma

Sponsor: Meiji Seika Pharma Co.,Ltd

Chair:	Motoko Yamaguchi (Department of Hematology and Oncology, Mie University Graduate School of Medicine)
Speaker:	Ritsuro Suzuki (Department of Oncology and Hematology, Shimane University Hospital)

Ⓔ Morning Seminar　MS3-2

Sunday, October 22　8:00-8:45 No. 2 (Hall Building Hall B7(1), 7F)

Long-term efficacy and safety of Ibrutinib in CLL/SLL patients

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Koichi Akashi (Department of Medicine and Biosystemic Science Kyushu University Faculty of Medicine)
Speaker:	Peter Hillmen (Experimental Haematology University of Leeds)

Morning Seminar　MS3-3

Sunday, October 22　8:00-8:45 No. 3 (Hall Building Hall B7(2), 7F)

Iron metabolism and Iron overload/Iron chelation therapy ~ update ~

Sponsor: Novartis Pharma K.K.

Chair:	Hideo Harigae (Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine)
Speaker:	Katsuya Ikuta (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University)

Morning Seminar　MS3-4

Sunday, October 22　8:00-8:45 No. 4 (Hall Building Hall B5(1), 5F)

Invasive fungal infections in adults with hematologic malignancies -Up to Date-

Sponsor: Pfizer Japan Inc.

Chair:	Takanori Teshima (Department of Hematology, Hokkaido University Graduate School of Medicine)
Prophylaxis against fungal infection in hematopoietic stem cell transplantation
Speaker:	Takehiko Mori (Division of Hematology, Keio University School of Medicine)
Current approaches to antifungal therapy
Speaker:	Yasushi Onishi (Department of Hematology and Rheumatology, Tohoku University Hospital)

Morning Seminar　MS3-5

Sunday, October 22　8:00-8:45 No. 5 (Hall Building Hall B5(2), 5F)

Novel cancer-stem cell-targeted therapy for hematological malignancy

Sponsor: Sumitomo Dainippon Pharma Co.,Ltd. Oncology Medical Affairs

Chair:	Mineo Kurokawa (Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo)
Speaker:	Issay Kitabayashi (Division of Hematological Malignancy, National Cancer Center Research Institute)

Morning Seminar　MS3-6

Sunday, October 22　8:00-8:45 No. 6 (Hall Building Hall D7, 7F)

Diagnosis of bone marrow failure -Possibility of Gaucher disease lurking in thrombocytopenia-

Sponsor: Sanofi K.K.

Chair:	Hiroshi Kawabata (Department of Hematology and Immunology, Kanazawa Medical University)
Speaker:	Akira Matsuda (Department of Hemato-Oncology, International Medical Center, Saitama Medical University)

Morning Seminar　MS3-7

Sunday, October 22　8:00-8:45 No. 7 (Hall Building Hall D5, 5F)

Allogeneic hematopoietic stem cell transplantation for MDS

Sponsor: Astellas Pharma Inc.

Chair:	Yuzuru Kanakura (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)
Speaker:	Kazuteru Ohashi (Hematology Division Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital)

Morning Seminar　MS3-9

Sunday, October 22　8:00-8:45 No. 9 (Glass Building G402, 4F)

CML - Treatment Strategy for TFR　

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Hiroyoshi Nishikawa (National Cancer Center Research Institute)
Speaker:	Fumihiko Kimura (Hematology, National Defense Medical College)

Morning Seminar　MS3-10

Sunday, October 22　8:00-8:45 No. 10 (Glass Building G409, 4F)

Continuous therapy with proteasome inhibitor ～ a novel treatment paradigm

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Chihiro Shimazaki (Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center)
Speaker:	Hiroshi Handa (Gunma University Hospital Hemalotogy)

Morning Seminar　MS3-11

Sunday, October 22　8:00-8:45 No. 11 (Glass Building G502, 5F)

Molecular Pathogenesis of B-cell Lymphoma

Sponsor: Medical Division, Eisai Co., Ltd.

Chair:	Koji Izutsu (Department of Hematology, National Cancer Center Hospital)
Speaker:	Momoko Nishikori (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Ⓔ Morning Seminar　MS3-12

Sunday, October 22　8:00-8:45 No. 12 (Glass Building G510, 5F)

Management of Relapsed/Refractory Multiple Myeloma～Optimal use of Carfilzomib～

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:	Tadao Ishida (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.)
Speaker:	Hermann Einsele (University Hospital Wüerzburg, Department of Internal Medicine II)

Morning Seminar　MS3-13

Sunday, October 22　8:00-8:45 No. 13 (Glass Building G602, 6F)

New stage of treatment for Hemophilia B ; How QOL of Hemophilia B patients changes

Sponsor: CSL Behring K.K.

Chair:	Akira Shirahata (University of Occupational and Environmental Health)
Speaker:	Chiai Nagae (St. Marianna University School of Medicine, Department of Pediatrics)

Ⓔ Luncheon Seminar　LS3-2

Sunday, October 22　12:25-13:10 No. 2 (Hall Building Hall B7(1), 7F)

Current and future management of FL referring to biomarkers/response criteria surrogate marker

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:	Akihiro Tomita (Fujita Health University School of Medicine Department of Hematology)
Speaker:	Michele Ghielmini (Oncology Institute of Southern Switzerland in Bellinzona, Switzerland)

Ⓔ Luncheon Seminar　LS3-3

Sunday, October 22　12:25-13:10 No. 3 (Hall Building Hall B7(2), 7F)

Multiple Myeloma: Changing the present, Creating the future

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Junya Kuroda (Department of Hematology, Kyoto Prefectural University of Medicine)
Speaker:	Suzanne Lentzsch (Columbia University Medical Center, USA)

Ⓔ Luncheon Seminar　LS3-4

Sunday, October 22　12:25-13:10 No. 4 (Hall Building Hall B5(1), 5F)

Combinations of novel agents in the treatment of Multiple Myeloma

Sponsor: Fujimoto Pharmaceutical Corp.

Chair:	Kazuyuki Shimizu (National Hospital Organization Higashinagoya National Hospital)
Speaker:	Pieter Sonneveld (Erasmus MC Cancer Institute)

Ⓔ Luncheon Seminar　LS3-5

Sunday, October 22　12:25-13:10 No. 5 (Hall Building Hall B5(2), 5F)

The 3rd generation TKI for Ph+leukemia treatment

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:	Koichi Miyamura (Japanese Red Cross Nagoya Daiichi Hospital)
Speaker:	Elias Jabbour (Leukemia Department, MD Anderson Cancer Center)

Luncheon Seminar　LS3-6

Sunday, October 22　12:25-13:10 No. 6 (Hall Building Hall D7, 7F)

Track of blood coagulation factor VII and Future prospects

Sponsor: Novo Nordisk Pharma Ltd.

Chair:	Tadashi Matsushita (Department of Transfusion Medicine, Nagoya University Hospital)
Speaker:	Keiji Nogami (Department of Pediatrics, Nara Medical University)

Ⓔ Luncheon Seminar　LS3-7

Sunday, October 22　12:25-13:10 No. 7 (Hall Building Hall D5, 5F)

Considerations for TKI treatment in CML

Sponsor: Pfizer Japan Inc.

Chair:	Naoto Takahashi (Akita University Graduate school of Medicine and Faculty of Medicine, Department of Hematology, Nephrology, and Rheumatology)
Speaker:	Jorge Eduardo Cortes (Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

Luncheon Seminar　LS3-8

Sunday, October 22　12:25-13:10 No. 8 (Hall Building Hall D1, 1F)

The role for Kovaltry in patients of all ages: Lessons from Ogikubo experience

Sponsor: Bayer Yakuhin, Ltd.

Chair:	Katsuyuki Fukutake (Department of Laboratory Medicine, Tokyo Medical University Hospital)
Speaker:	Azusa Nagao (Department of blood coagulation, Ogikubo hospital)

Luncheon Seminar　LS3-9

Sunday, October 22　12:25-13:10 No. 9 (Glass Building G402, 4F)

Molecular mechanisms of AML leukemogenesis and novel therapeutic strategies

Sponsor: Gilead Sciences

Chair:	Tomoki Naoe (National Hospital Organizaion Nagoya Medical Center)
Speaker:	Yoshikane Kikushige (Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine)

Luncheon Seminar　LS3-10

Sunday, October 22　12:25-13:10 No. 10 (Glass Building G409, 4F)

The role of microenvironment in malignant lymphoma

Sponsor: Sumitomo Dainippon Pharma Co.,Ltd.

Chair:	Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)
Speaker:	Koji Kato (Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science)

Ⓔ Luncheon Seminar　LS3-11

Sunday, October 22　12:25-13:10 No. 11 (Glass Building G502, 5F)

Precision molecules changing the treatment landscape of AML

Sponsor: AbbVie GK

Chair:	Kinuko Mitani (Dokkyo Medical University)
Speaker:	Andrew Wei (Monash University, Australia Head Human Molecular Pathology, Alfred Hospital, Australia)

Luncheon Seminar　LS3-12

Sunday, October 22　12:25-13:10 No. 12 (Glass Building G510, 5F)

The role of Fc fusion rFVIII/rFIX products in the treatment of Hemophilia

Sponsor: Bioverativ Japan Ltd.

Chair:	Kagehiro Amano (Department of Laboratory Medicine, Tokyo Medical University)
Speaker:	Takashi Suzuki (Department of Hematology, Ogikubo Hospital)

Ⓔ Luncheon Seminar　LS3-13

Sunday, October 22　12:25-13:10 No. 13 (Glass Building G602, 6F)

T-cell lymphomas: contemporary treatment strategies

Sponsor: mundipharma K.K.

Chair:	Kensei Tobinai (National Cancer Center Hospital)
Speaker:	Andrei Shustov (Division of Hematology University of Washington)

Luncheon Seminar　LS3-14

Sunday, October 22　12:25-13:10 No. 14 (Glass Building G610, 6F)

Cell therapy for steroid-refractory acute GVHD

Sponsor: JCR Pharmaceuticals Co., Ltd

Chair:	Tatsuo Ichinohe (Department of Hematology and Oncology Research Institute for Radiation Biology and Medicine Hiroshima University)
Speaker:	Takashi Ikeda (Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan)

Ⓔ Luncheon Seminar　LS3-15

Sunday, October 22　12:25-13:10 No. 15 (Glass Building G701, 7F)

Latest Advances in Autologous Stem Cell Mobilization

Sponsor: Sanofi K.K.

Chair:	Shinichiro Okamoto (Division of Hematology, Department of Medicine, Keio University School of medicine)
Speaker:	Mohamad Mohty (Department of Hematology, Hematology and cellular therapy Department, Hospital Saint-Antoine, and University Pierre & Marie Curie, Paris, France)